DOCSLIB.ORG

Marketsandmarkets Publisher Sample

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

MarketsandMarkets http://www.marketresearch.com/MarketsandMarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm EST Fridays: 5:30am - 5:30pm EST Email: [email protected] MarketResearch.com BIOINFORMATICS MARKET BY SECTOR (MOLECULAR MEDICINE, AGRICULTURE, FORENSIC, ANIMAL, RESEARCH & GENE THERAPY), SEGMENT (SEQUENCING PLATFORMS, KNOWLEDGE MANAGEMENT & DATA ANALYSIS) & APPLICATION (GENOMICS, PROTEOMICS & METABOLOMICS) GLOBAL FORECAST TO 2020 MARKETSANDMARKETS [email protected] It ’s a ll a b o u t m a rke ts www.marketsandmarkets.com Bioinformatics Market – Global Forecast To 2020 MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. Copyright © 2015 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets. 2 © MarketsandMarkets Sample Pages Bioinformatics Market – Global Forecast To 2020 1 INTRODUCTION 1.1 MARKET DEFINITION Bioinformatics is the application of computer technology for the management and analysis of biological data. 1.2 MARKET SCOPE BIOINFORMATICS MARKET Sectors Products & Services Applications Regions Knowledge Management Medical Biotechnology Genomics North America Tools Chemoinformatics & Academics Platforms Europe Drug Design Animal Biotechnology Services Proteomics APAC Agricultural Transcriptomics RoW Biotechnology Environmental Metabolomics Biotechnology Forensic Biotechnology Molecular Phylogenetics Others* Others** Others** include Glycomics, Cytomics, Physiomics, and Interactomics Others* include Home Land Security and Defence, Law Enforcement Groups, Bioweapon Creation, and Evolutionary Biotechnology 3 © MarketsandMarkets Sample Pages Bioinformatics Market – Global Forecast To 2020 2 RESEARCH METHODOLOGY 2.1 MARKET BREAKDOWN AND DATA TRIANGULATION FIGURE 1 DATA TRIANGULATION METHODOLOGY PRIMARY SOURCES SECONDARY SOURCES Interviews with: Annual Reports, Presentations, • Researchers Websites and Press Releases • Bioinformatics Technicians of Top Players, News Articles, • Purchase Managers in MnM KNOW* Journals, and Paid Databases Academics and Pharmaceutical & Demand Side Biotechnology Companies • Genome Canada (PEC) • National Institute of health (NIH) Interviews with: Primary Secondary • CEOs Sources Sources • World Health Organization (WHO) • Vice Presidents • National Human genome Research • Marketing Directors DATA TRIANGULATION Institute • Technology and Innovation Directors and Related Key Executives from Various Key Supply Side Supply Companies and Organizations Operating in the Bioinformatics Market Information Sourced Opportunities and Market Size (2014) and Key Players Competitive Landscape Challenges Market Share (2014) Drivers and Restraints Forecast Geographical Analysis MnM KNOW* stands for ‘MarketsandMarkets Knowledge Asset Management' framework. In this context, it stands for the existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject-matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources . 4 © MarketsandMarkets Sample Pages Bioinformatics Market – Global Forecast To 2020 2.1.1 KEY DATA FROM SECONDARY SOURCES PARAMETER SECONDARY SOURCES . Company Financials . Magazines . Journals 1 Market Size . Press Releases . Paid Databases . MarketsandMarkets Data Repository . Annual Reports Revenue . Company Websites 2 of Companies . Public Databases . MarketsandMarkets Data Repository . Company Websites Qualitative Information . Annual Reports 3 (Market Dynamics and Trends) . Press Releases . MarketsandMarkets Data Repository 5 © MarketsandMarkets Sample Pages Bioinformatics Market – Global Forecast To 2020 3 PREMIUM INSIGHTS 3.1 GLOBAL BIOINFORMATICS MARKET, BY PRODUCTS AND SERVICES FIGURE 2 BIOINFORMATICS PLATFORMS SEGMENT IS EXPECTED TO DOMINATE THE MARKET CAGR% CAGR% CAGR% Market Size 2020 (2015–2020) (2015–2020) (2015-2020) ($Million) North America XX XX XX Europe XX XX XX Asia-Pacific XX XX XX Knowledge Management Tools RoW Bioinformatics Platforms XX XX XX Bioinformatics Services Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Oxford Journals, National Human Genome Research Institute (NHGRI), EMBL-European Bioinformatics Institute (EMBL-EBI), National Center for Biotechnology Information (NCBI), Genome Canada, Expert Interviews, and MarketsandMarkets Analysis 3.2 GLOBAL BIOINFORMATICS MARKET, BY APPLICATION FIGURE 3 GENOMICS SEGMENT OFFERS LUCRATIVE GROWTH OPPORTUNITIES Market Size ($Million) XX% 4,500.0 2014 4,000.0 XX% XX% 2020 3,500.0 CAGR% (2015–2020) 3,000.0 2,500.0 2,000.0 XX% 1,500.0 XX XX% XX XX XX% 1,000.0 XX% XX 500.0 XX XX XX XX XX XX XX XX XX XX 0.0 Genomics Chemoinformatics Proteomics Transcriptomics Metabolomics Molecular Others & Drug Design Phylogenetics Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, Oxford Journals, National Human Genome Research Institute (NHGRI), EMBL-European Bioinformatics Institute (EMBL-EBI), National Center for Biotechnology Information (NCBI), Genome Canada, Expert Interviews, and MarketsandMarkets Analysis 6 © MarketsandMarkets Sample Pages Bioinformatics Market – Global Forecast To 2020 4 MARKET OVERVIEW 4.1 MARKET DYNAMICS 4.1.1 DRIVERS 4.1.1.1 Growing demand for nucleic acid and protein sequencing Bioinformatics is increasingly being used to identify genes on the DNA sequence. The information collected is used to understand the molecular mechanisms of the disease. This assists in developing better treatments, cures, as well as preventative tests. Previously, sequencing-related projects were not affordable to small research centers and companies due to the high cost of sequencing. However, due reduced costs, many scientific research institutes and biotech companies have taken initiatives to perform sequencing studies. Similarly, sequencing can now be completed within months after the development of bioinformatics tools. As the speed of decoding genetic sequences has increased, the overall cost of sequencing also decreased from 10 dollars per base in 1990 to 10 cents per base by 2003. As a result, the number of companies participating in DNA sequencing projects is increasing owing to reduced costs. This is driving the growth of the bioinformatics market. 4.1.1.2 Increasing funding from government and private organizations Government and private organizations are increasingly investing in the field of bioinformatics to further develop the understanding of the human and microbial genome at the molecular level. In this regard, in April 2013, the Canadian government invested $XX million to enhance bioinformatics and computational biology tools and methodologies which are used in genomics research. This funding helped develop tools for providing better treatments to treat cancer. 4.1.1.3 Rising initiatives by research institutes Initiatives taken by research institutes to provide training for the use of bioinformatics are contributing to the growth of market. For instance, in 2014, Intelligent Systems for Molecular Biology (ISMB) conducted a training in Boston(U.S.) which included computational biologists working and running bioinformatics core facilities. Similarly, in February 2013, the European Bioinformatics Institute, Cambridge (U.K.) initiated the European Molecular Biology Organization (EMBO)practical course on new techniques in metabolomics and usage of various bioinformatics tools. This course aimed to improve ability of researchers to perform researches related with metabolomics and bioinformatics. 4.1.1.4 Increasing information technology (IT) support Over the last few years, there have been many partnerships signed between IT and bioinformatics companies. These partnerships aimed to facilitate the development of bioinformatics tools and databases. In April 2013, Integromics (Spain), the Leibniz Supercomputing Centre in Munich-LRZ (Germany), the Johannes Kepler University of Linz-JKU (Austria), RISC Software (Austria), and Carlos Haya Hospital (Spain) synergized to form a new association for the development of IT solutions. The purpose of this association was to further develop bioinformatics services involved in the analysis and management of macro-datasets produced from genomics research. This association also assists clinical applications based on macro datasets. Thus, growing IT support for the development of bioinformatics is significantly contributing to the growth of bioinformatics market. 7 © MarketsandMarkets Sample Pages Bioinformatics Market – Global Forecast To 2020 4.1.1.5 Growing applications of bio informatics in drug discovery
Recommended publications
  • Development of Virtual Screening and in Silico Biomarker Identification Model for Pharmaceutical Agents

    Development of Virtual Screening and in Silico Biomarker Identification Model for Pharmaceutical Agents

    DEVELOPMENT OF VIRTUAL SCREENING AND IN SILICO BIOMARKER IDENTIFICATION MODEL FOR PHARMACEUTICAL AGENTS ZHANG JINGXIAN NATIONAL UNIVERSITY OF SINGAPORE 2012 Development of Virtual Screening and In Silico Biomarker Identification Model for Pharmaceutical Agents ZHANG JINGXIAN (B.Sc. & M.Sc., Xiamen University) A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF PHARMACY NATIONAL UNIVERSITY OF SINGAPORE 2012 Declaration Declaration I hereby declare that this thesis is my original work and it has been written by me in its entirety. I have duly acknowledged all the sources of information which have been used in the thesis This thesis has also not been submitted for any degree in any university previously. Zhang Jingxian Acknowledgements Acknowledgements First and foremost, I would like to express my sincere and deep gratitude to my supervisor, Professor Chen Yu Zong, who gives me with the excellent guidance and invaluable advices and suggestions throughout my PhD study in National University of Singapore. Prof. Chen gives me a lot help and encouragement in my research as well as job-hunting in the final year. His inspiration, enthusiasm and commitment to science research greatly encourage me to become research scientist. I would like to appreciate him and give me best wishes to him and his loving family. I am grateful to our BIDD group members for their insight suggestions and collaborations in my research work: Dr. Liu Xianghui, Dr. Ma Xiaohua, Dr. Jia Jia, Dr. Zhu Feng, Dr. Liu Xin, Dr. Shi Zhe, Mr. Han Bucong, Ms Wei Xiaona, Mr. Guo Yangfang, Mr. Tao Lin, Mr. Zhang Chen, Ms Qin Chu and other members.
  • 2012 Single Cell Analysis Workshop

    2012 Single Cell Analysis Workshop

    2012 Single Cell Analysis Workshop Where: Hyatt Regency, Bethesda MD When: April 17-18, 2012 Co-chairs: Dr. Gary Nolan (Stanford University) and Dr. Nancy Allbritton (University of North Carolina) The NIH Common Fund held a Single Cell Analysis meeting on April 17-18, 2012 in Bethesda, MD. The objective was to provide a forum to bring together a multidisciplinary group of investigators and federal staff to discuss the latest technological advances and transformative discoveries in the area of single cell analysis. The focus was on approaches that further our understanding of cell heterogeneity or variation, including identifying unique cell types and cell “states”. The goal was to share knowledge and accelerate the dissemination of technological advances within the relevant research community. The format incorporated short talks, poster presentations, and panel discussions providing the group with opportunities to review recent progress and consider the major challenges facing the field over the next decade. There were over 90 registered participants from academia as well as the public and private sectors with 20 attendees presenting posters during two day meeting. Four presentation/discussion sessions were held. A general description and summary of each follows. Session 1—Profiling Individual Cell State: Genomics Roger Lasken, Craig Venter Institute Barbara Wold, California Institute of Technology Robert Singer, Albert Einstein College of Medicine Paul Soloway, Cornell University Junhyong Kim, University of Pennsylvania Presenters discussed sequencing whole genomes at the level of a single cell or single nuclei; measuring and visualizing RNA expression and localization including technical challenges associated with multiplexed analyses; advances in single cell epigenomic analysis; and bioinformatics and computational questions using genomic/transcriptomic data from single cell experiments.
  • Funding Opportunities for Research Announcements

    Funding Opportunities for Research Announcements

    Newsletter funding opportunities for research Announcements Alcohol, Drugs or Abuse &/or Smoking Men’s & Women’s Health Bioimaging and Radiation Research Miscellaneous Bioinformatics Musculoskeletal Biomedical Technology Nanomedicine/Nanotechnology Cancer & Blood Neurosciences Complementary & Alternative Medicine Nursing; Practice & Outcomes Research (CAM) Nutrition Cytomics Oral Cavity/Dentistry Diabetes, Endocrine & Metabolism Patient Oriented Research Digestive & Liver Pediatrics Education & Curriculum Development Pharmacy & Pharmacology Research Emergency Medicine Prizes & Awards Equipment Psychobehavioral Research/Mental Health Eyes, Ears, Nose, Throat Public Health Family Medicine Regenerative Medicine/Transplantation Genomics Skin Geriatrics/Aging Structural Biology & Proteomics Heart & Vascular Diseases Therapies & Therapeutics Immunology Training & Fellowships Infectious Disease/Biopreparedness Kidney & Urinary System NOTICES Lung and Sleep Click on a topic be taken to the page where that topic is bookmarked in the main body of the document and you can read each funding opportunity listed under that topic. Home will get you back to this page where you can select another topic. Current and archived newsletters can also be accessed on-line. Go to http://www.unmc.edu/vcr/fundingopportunities.htm 1 Volume 6, Issue 7 March 05, 2010 NOTICES Notice of Availability of Administrative Supplements for R25 Science Education Grants New NOT-DA-10-007 National Institutes of Health Blueprint for Neuroscience Research multiple institutes The National Institutes of Health Blueprint for Neuroscience Research announces an administrative supplement program of $600,000 in Fiscal Years 2010 and 2011 to provide funds to Blueprint Institute-supported research education projects (see Eligibility section below). The purpose of this program is to create and broadly disseminate materials/programs to inform students and teachers in kindergarten- 12th grade about the field of neuroscience.
  • 41 Nanoneuroscience and Nanoneurosurgery

    41 Nanoneuroscience and Nanoneurosurgery

    Nanoneuroscience and 41 Nanoneurosurgery A Key Component of President Obama’s Brain Mapping Initiative Babak Kateb,* Vicky Yamamoto, Peter J. Basser, Michael Roy, Lucien M. Levy, Jian Tajbakhsh, Gary K. Steinberg, Allyson C. Rosen, Keith L. Black, Charlie Teo, Kuldip Sidhu, Mitchel S. Berger, and Warren S. Grundfest CONTENTS Introduction .................................................................................................................................... 547 Problem to Be Addressed ...............................................................................................................549 The National Alliance for NanoBioElectonics (NANBE) in Brain Mapping ........................... 550 National Network for Human Brain and Specimen Banks (NNHBSB) ................................... 550 National Data Repository and Analysis for Neuroscience (NDRAN) ...................................... 551 Purpose ........................................................................................................................................... 552 Significance of the Proposed Approach and Its Impact on the Field of Brain Mapping ............... 553 Programs and Methods .................................................................................................................. 553 Conclusion ..................................................................................................................................... 554 References .....................................................................................................................................
  • New Technology for the Human Cytome Project

    New Technology for the Human Cytome Project

    Journal of Biological Regulators and Homeostatic Agents New technology for the human cytome project A. TÁRNOK Pediatric Cardiology, Heart Center Leipzig GmbH, University Hospital Leipzig, Leipzig, Germany ABSTRACT: Cytomes or cell systems are composed of various kinds of single-cells and constitute the elementary building units of organs and organisms. Their individualised (cytomic) analysis overcomes the problem of averaged results from cell and tissue homogenates where molecular changes in low frequency cell populations may be hidden and wrongly interpreted. Analysis of the cytome is of pivotal importance in basic research for the understanding of cells and their interrelations in complex environments like tissues and in predictive medicine where it is a prerequisite for individualised preventive therapy. Analysis of molecular phenotypes requires instrumentation that on the one hand provides high-throughput measurement of individual cells and is on the other hand highly multiplexed, enabling the simultaneous acquisition of many parameters on the single cell level. Upcoming technology suitable to this task, such as slide based cytometry is available or under development. The realisation of cytomic technology is important for the realisation of the human cytome project. (J Biol Regul Homeost Agents 2004; 18: ) KEY WORDS: Cytomics, Bioinformatics, Multilevel biocomplexity profiling, Slide based cytometry, Imaging, Human cytome project Received: Revised: Accepted: INTRODUCTION Slide based cytometry Cytomes, i.e. cell systems are composed
  • Research Report 2009 Max Planck Institute for Molecular Genetics, Berlin Imprint | Research Report 2009

    Research Report 2009 Max Planck Institute for Molecular Genetics, Berlin Imprint | Research Report 2009

    Research Report 2009 Max Planck Institute for Molecular Genetics, Berlin Imprint | Research Report 2009 Published by the Max Planck Institute for Molecular Genetics (MPIMG), Berlin, Germany, December 2009 Editorial Board: B.G. Herrmann, H. Lehrach, H.-H. Ropers, M. Vingron Conception & coordination: Patricia Marquardt Photography: Katrin Ullrich, MPIMG; David Ausserhofer Scientific Illustrations: MPIMG Production: Thomas Didier, Meta Data Contact: Max Planck Institute for Molecular Genetics Ihnestr. 63 – 73 14195 Berlin Germany Phone: +49 (0)30 8413-0 Fax: +49 (0)30 8413-1207 Email: [email protected] For further information about the MPIMG, please visit http://www.molgen.mpg.de MPI for Molecular Genetics Research Report 2009 Research Report 2009 1 Max Planck Institute for Molecular Genetics Berlin, December 2009 The Max Planck Institute for Molecular Genetics 2 MPI for Molecular Genetics Research Report 2009 Table of contents Organisational structure . 6 The Max Planck Institute for Molecular Genetics . 7 Mission . 7 Development of the Institute. 7 Research Concept . 8 Department of Developmental Genetics (Bernhard Herrmann) . 9 Transmission ratio distortion (H. Bauer) . 13 Regulatory Networks of Mesoderm Formation & Somitogenesis (B. Herrmann) . 17 Signal Transduction in Embryogenesis and Tumour Progression (M. Morkel) . 22 Organogenesis (H. Schrewe) . 26 General information about the whole Department . 29 Department of Vertebrate Genomics (Hans Lehrach) . 33 Molecular Embryology and Aging (J. Adjaye) . 40 Neuropsychiatric Genetics (L. Bertram) . 46 Automation (A. Dahl, W. Nietfeld, H. Seitz) . 49 Nucleic Acid-based Technologies (J. Glökler) . 55 Bioinformatics (R. Herwig) . 60 Comparative and Functional Genomics (H. Himmelbauer) . .65 Genetic Variation, Haplotypes & Genetics of Complex Diseases (M. Hoehe) . 69 3 in vitro Ligand Screening (Z.
  • A Human Cytome Project

    A Human Cytome Project

    A Human Cytome Project Peter Van Osta MAIA SCIENTIFIC European Microscopy Congress Antwerp, Belgium Friday 27August 2004 A Human Cytome Project • Definitions • Introduction and rationale • Research concepts • Proposal of a strategy • Round table discussion • Conclusion A Human Cytome Project • Definitions • Introduction and rationale • Research concepts • Proposal of a strategy • Round table discussion • Conclusion Cytome - Cytomics • Cytomes can be defined as cellular systems and subsystems and functional components of the body. • Cytomics is the study of the heterogeneity of cytomes or more precisely the study of molecular single cell phenotypes resulting from genotype and exposure in combination with exhaustive bioinformatics knowledge extraction. • The word Cytomics was first used in 2001 by: Davies E, Stankovic B, Azama K, Shibata K, Abe S. “Novel components of the plant cytoskeleton: A beginning to plant "cytomics" Plant Science, Invited Review, Plant Science (160)2 (2001) pp. 185-196. A Human Cytome Project • Definitions • Introduction and rationale • Research concepts • Proposal of a strategy • Round table discussion • Conclusion Why do we need a Human Cytome Project ? Human 30,000 genes Mouse 30,000 genes 3,2000 Mb or 3.2 billion base pairs 2,500 Mb C. elegans 19,000 genes Drosophila 13,601 genes 97 Mb 165 Mb Complexity and differentiation of organisms is not only explained from the relative complexity of their genomes From Genes to Proteins to Pathways From gene to 3D protein structure Metabolic pathways The complexity of interacting metabolic pathways is not only predicted from the gene or protein structure Environment - Cell – Genome A web of interactions Environment Cell From Gene to Protein Cytome Genome - Proteome Instead of concentrating on molecular targets within the relatively infinite network of highly redundant molecular pathways of cells, one can primarily focus on the end result, represented by molecular phenotypes of cells as a consequence of both genotype and environment.
  • Clinical Flow Cytometry, a Hypothesis-Driven Discipline of Modern Cytomics

    Clinical Flow Cytometry, a Hypothesis-Driven Discipline of Modern Cytomics

    Reprinted with permission of Cytometry Part A, John Wiley and Sons, Inc. © 2004 Wiley-Liss, Inc. Cytometry Part A 58A:87–97 (2004) Clinical Flow Cytometry, a Hypothesis-Driven Discipline of Modern Cytomics George Janossy* HIV Immunology, Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, London, United Kingdom Recently, two major books have been published that regulatory processes, and proteomics investigates the summarize the historical aspects and recent achievements abundance of proteins simultaneously with the changes of practical flow cytometry (1,2). Both emphasize the role associated with alterations of the functional state of the played by this newly developed technical discipline in the cell. Such a “pseudo-functional” approach aims to extend development of scientific (1) and diagnostic platforms the study of quantitative changes during differentiation, during late 20th-century medicine (2). Indeed, the gray proliferation, and signaling of different cell types (5). box called a flow cytometer is the result of a multidisci- Clearly, there is an enormous, newly generated influx of plinary collaboration between engineers, biophysicists, information here, but it is not certain that a mere analysis biochemists, histopathologists, molecular cytologists, he- of genes and protein structure, even in its extended for- matologists, immunologists, and quality controllers, with a mat that includes the interaction of various biomolecules, more recent contribution from physicians specializing in will provide all of the necessary information to understand the human immunodeficiency virus (HIV), oncologists, function and regulation at the level of living cells and and epidemiologists (Table 1). organisms. Hence, the concept of cytomics has been in- The foresight by the “fathers” has been astonishing (1).
  • Multi-Omics Data Integration Considerations and Study Design for Biological Systems and Disease Cite This: Mol

    Multi-Omics Data Integration Considerations and Study Design for Biological Systems and Disease Cite This: Mol

    Molecular Omics View Article Online REVIEW View Journal | View Issue Multi-omics data integration considerations and study design for biological systems and disease Cite this: Mol. Omics, 2021, 17, 170 Stefan Graw,a Kevin Chappell,a Charity L. Washam,ab Allen Gies,a Jordan Bird,a Michael S. Robeson II *c and Stephanie D. Byrum *ab With the advancement of next-generation sequencing and mass spectrometry, there is a growing need for the ability to merge biological features in order to study a system as a whole. Features such as the transcriptome, methylome, proteome, histone post-translational modifications and the microbiome all influence the host response to various diseases and cancers. Each of these platforms have technological limitations due to sample preparation steps, amount of material needed for sequencing, and sequencing depth requirements. These features provide a snapshot of one level of regulation in a system. The obvious next step is to integrate this information and learn how genes, proteins, and/or epigenetic factors influence the phenotype of a disease in context of the system. In recent years, there has been a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. push for the development of data integration methods. Each method specifically integrates a subset of omics data using approaches such as conceptual integration, statistical integration, model-based Received 1st April 2020, integration, networks, and pathway data integration. In this review, we discuss considerations of the Accepted 29th June 2020 study design for each data feature, the limitations in gene and protein abundance and their rate of DOI: 10.1039/d0mo00041h expression, the current data integration methods, and microbiome influences on gene and protein expression.
  • DNA Sequence Alignments - Best for Showing Identity  Protein Sequence Alignments Best for Showing Similarity You Shouldn’T Have to Work with Limiting Information

    DNA Sequence Alignments - Best for Showing Identity  Protein Sequence Alignments Best for Showing Similarity You Shouldn’T Have to Work with Limiting Information

    An Introduction to Bioinformatics Mohamed Abdel-Hakim Mahmoud Genetics Department, Faculty of Argiculture, Minia University, El-Minia, EGYPT WHAT IS BIOINFORMATICS? Applying ―informatics‖ techniques from math, statistics and computer science, to understand and organize the information associated with biological molecules on a large scale Can be defined as the body of tools, algorithms needed to handle large and complex biological information. Bioinformatics is a new scientific discipline created from the interaction of biology and computer. Bioinformatics is clearly a multi-disciplinary field including: the use of mathematical, statistical and computing methods for the organization, management, analysis & interpretation of biological information (DNA, amino acid sequences and related information) that aim to solve biological problems. More Definition The NCBI defines Bioinformatics as: a field of science in which biology, computer science, and information technology merge into a single discipline‖ In Wikipedia: Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data, in particular when the data sets are large and complex. As an interdisciplinary field of science, bioinformatics combines biology, computer science, information engineering, mathematics and statistics to analyze and interpret the biological data. Bioinformatics has been used for in silico analyses of biological queries using mathematical and statistical techniques. Roughly, Bioinformatics describes any
  • Omics and Integrated Omics for the Promotion of Food and Nutrition Science

    Omics and Integrated Omics for the Promotion of Food and Nutrition Science

    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Journal of Traditional and Complementary Medicine Vol. 1, No. 1, pp. 25-30 Copyright © 2011 Committee on Chinese Medicine and Pharmacy, Taiwan This is an open access article under the CC BY-NC-ND license. :ŽƵƌŶĂůŽĨdƌĂĚŝƚŝŽŶĂůĂŶĚŽŵƉůĞŵĞŶƚĂƌLJDĞĚŝĐŝŶĞ Journal homepagĞŚƩƉ͗ͬͬǁǁǁ͘ũƚĐŵ͘Žƌg Omics and Integrated Omics for the Promotion of Food and Nutrition Science Hisanori Kato*, Shoko Takahashi and Kenji Saito Food for Life, Organization for Interdisciplinary Research Projects, The University of Tokyo Abstract Transcriptomics, proteomics, and metabolomics are three major platforms of comprehensive omics analysis in the science of food and complementary medicine. Other omics disciplines, including those of epigenetics and microRNA, are matters of increasing concern. The increased use of the omics approach in food science owes much to the recent advancement of technology and bioinformatic methodologies. Moreover, many researchers now put the combination of multiple omics analysis (integrated omics) into practice to exhaustively understand the functionality of food components. However, data analysis of integrated omics requires huge amount of work and high skill of data handling. A database of nutritional omics data was constructed by the authors, which should help food scientists to analyze their own omics data more effectively. In addition, a novel tool for the easy visualization of omics data was developed by the authors’ group. The tool enables one to overview the changes of multiple omics in the KEGG pathway. Research in traditional and complementary medicine will be further facilitated by promoting the integrated omics research of food functionality. Such integrated research will only be possible with the effective collaboration of scientists with different backgrounds.
  • Integrated Omics: Tools, Advances and Future Approaches

    Integrated Omics: Tools, Advances and Future Approaches

    62 1 Journal of Molecular B B Misra et al. Approaches and tools in 62:1 R21–R45 Endocrinology integrated omics REVIEW Integrated omics: tools, advances and future approaches Biswapriya B Misra1, Carl Langefeld1,2, Michael Olivier1 and Laura A Cox1,3 1Center for Precision Medicine, Section on Molecular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North California, USA 2Department of Biostatistics, Wake Forest School of Medicine, Winston-Salem, North California, USA 3Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, Texas, USA Correspondence should be addressed to L A Cox: [email protected] Abstract With the rapid adoption of high-throughput omic approaches to analyze biological Key Words samples such as genomics, transcriptomics, proteomics and metabolomics, each f integrated analysis can generate tera- to peta-byte sized data files on a daily basis. These data file f omics sizes, together with differences in nomenclature among these data types, make the f genomics integration of these multi-dimensional omics data into biologically meaningful context f transcriptomics challenging. Variously named as integrated omics, multi-omics, poly-omics, trans-omics, f proteomics pan-omics or shortened to just ‘omics’, the challenges include differences in data f metabolomics cleaning, normalization, biomolecule identification, data dimensionality reduction, f network biological contextualization, statistical validation, data storage and handling, sharing and f statistics data archiving. The ultimate goal is toward the holistic realization of a ‘systems biology’ f Bayesian understanding of the biological question. Commonly used approaches are currently f machine learning limited by the 3 i’s – integration, interpretation and insights.